4th Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for JOHNSON & JOHNSON SERVICES, INC.

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R.3590-Patient Protection and Affordable Care Act, provisions relating to medical devices

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3590 (111th)

Health Issues HCR

Biosimilars; Pre-emption; Legal Reform; Importation; Health Care Reform S.1796-America's Healty Future Act of 2009, provisions relating to biosimilars H.R.3200-America's Affordable Health Choices Act of 2009, provisions relating to biosimilars H.R.1548-Pathway for Biosimilars Act H.R.1427-Promoting Innovation and Access to Lifesaving Medicine Act S.726-Promoting Innovation and Access to Lifesaving Medicine Act S.525-Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590-Patient Protection and Affordable Care Act, provisions relating to biosimilars S.1679-Affordable Health Choice Act, provisions relating to biosimilars H.R.3962-Affordable Health Care for America Act, provisions relating to biosimilars

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1796 (111th), S. 1679 (111th), H.R. 3200 (111th), H.R. 1427 (111th), S. 525 (111th), H.R. 1548 (111th), H.R. 3962 (111th), H.R. 3590 (111th), S. 726 (111th)

Medical/Disease Research/Clinical Labs MED

Biosimilars Pre-emption; legal reform Health care reform

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.